ChiCTR2600115947 版本V1.0 版本创建时间2026/01/04 10:20:23 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600115947 

最近更新日期:

Date of Last Refreshed on:

2026-01-04 10:20:18 

注册时间:

Date of Registration:

2026-01-04 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

三叉神经节(人体捐献组织)的多组学研究

Public title:

Multi-omics study of the trigeminal ganglion (human donated tissues)

注册题目简写:

English Acronym:

研究课题的正式科学名称:

三叉神经节(人体捐献组织)的多组学研究

Scientific title:

Multi-omics study of the trigeminal ganglion (human donated tissues)

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

李凤仙 

研究负责人:

李凤仙 

Applicant:

Fengxian Li 

Study leader:

Fengxian Li 

申请注册联系人电话:

Applicant telephone:

+86 20 6278 2857

研究负责人电话:

Study leader's telephone:

+86 20 6278 2857

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

lifengxian81@smu.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

lifengxian81@smu.edu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广东省广州市海珠区工业大道中253号

研究负责人通讯地址:

广东省广州市海珠区工业大道中253号

Applicant address:

No. 253, Gongye Avenue, Haizhu District, Guangzhou City, Guangdong Province

Study leader's address:

No. 253, Gongye Avenue, Haizhu District, Guangzhou City, Guangdong Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

南方医科大学珠江医院

Applicant's institution:

Zhujiang Hospital of Southern Medical University

研究负责人所在单位:

南方医科大学珠江医院

Affiliation of the Leader:

Zhujiang Hospital of Southern Medical University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2025-KY-432-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

南方医科大学珠江医院临床研究和科研伦理委员会

Name of the ethic committee:

Clinical Research and Research Ethics Committee of Zhujiang Hospital, Southern Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2025-11-14 00:00:00

伦理委员会联系人:

黄熙华

Contact Name of the ethic committee:

Xihua Huang

伦理委员会联系地址:

广东省广州市海珠区工业大道中253号

Contact Address of the ethic committee:

No. 253, Gongye Avenue, Haizhu District, Guangzhou City, Guangdong Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 20 62783254

伦理委员会联系人邮箱:

Contact email of the ethic committee:

huang.xihua@qq.com

研究实施负责(组长)单位:

南方医科大学珠江医院

Primary sponsor:

Zhujiang Hospital of Southern Medical University

研究实施负责(组长)单位地址:

广东省广州市海珠区工业大道中253号

Primary sponsor's address:

No. 253, Gongye Avenue, Haizhu District, Guangzhou City, Guangdong Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东省

市(区县):

Country:

China

Province:

Guangdong

City:

单位(医院):

南方医科大学珠江医院

具体地址:

广东省广州市海珠区工业大道中253号

Institution
hospital:

Zhujiang Hospital of Southern Medical University

Address:

No. 253, Gongye Avenue, Haizhu District, Guangzhou City, Guangdong Province

经费或物资来源:

国家自然科学基金

Source(s) of funding:

National Natural Science Foundation of China

Target disease:

None

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

探究三叉神经节的神经节内细胞群组与细胞分子特征  

Objectives of Study:

Investigation of the ganglion-intrinsic cell populations and cellular molecular characteristics of the trigeminal ganglion

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.符合国家发育和功能人脑组织资源库与联盟单位的人体捐献标准; 2.死亡到取材时间在 24 小时内; 3.年龄>18 岁,性别不限

Inclusion criteria

1. Comply with the human donation standards of the National Developmental and Functional Human Brain Tissue Resource Bank and alliance units; 2. The time from death to sample collection is within 24 hours; 3. Age over 18 years old, gender not limited

排除标准:

1.样本组织存在损坏或RNA/蛋白质降解风险;
2.不符合多组学测序的质控要求;

Exclusion criteria:

1.The sample tissue is at risk of damage or RNA/protein degradation.
2.Does not meet the quality control requirements for multi-omics sequencing;

研究实施时间:

Study execute time:

From 2026-01-01 00:00:00 To 2026-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-01-04 00:00:00 To 2026-12-31 00:00:00  

干预措施:

Interventions:

组别:

三叉神经节观察组

样本量:

10

Group:

Trigeminal ganglion Observation group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东省 

市(区县):

 

Country:

China 

Province:

Guangdong 

City:

 

单位(医院):

南方医科大学珠江医院 

单位级别:

三级甲等 

Institution
hospital:

Zhujiang Hospital of Southern Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

多组学信息

指标类型:

主要指标

Outcome:

Multi-omics information

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

一般资料

指标类型:

次要指标

Outcome:

General Information

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

三叉神经节

组织:

Sample Name:

Trigeminal ganglion

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

EDC

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

EDC

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2026-01-04 10:20:18